GAIN THERAPEUTICS INC (GANX:NASDAQ)

$1.15 -0.11 (-8.7302%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 69

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed GAIN THERAPEUTICS INC (GANX:NASDAQ) News Sources

3 Parkinson's Biotech Stocks Analysts Think Are Wildly Mispriced

22-05-2026

yahoo.com

external link

Gain Therapeutics expands ‘compelling’ evidence base for Parkinson’s candidate

27-05-2026

yahoo.com

external link

Gain Therapeutics to Present at H.C. Wainwright 7th Annual Neuro Perspectives Expert Summit

10-06-2026

yahoo.com

external link

Gain Therapeutics Receives FDA Clearance of IND to Advance GT-02287 into Phase 2 Clinical Development for Parkinson’s Disease

29-06-2026

yahoo.com

external link

Gain Therapeutics CEO Gene Mack Issues Letter to Shareholders and Provides Operational Update

16-07-2026

yahoo.com

external link

Gain Therapeutics to Participate at H.C. Wainwright 28th Annual Global Investment Conference

25-08-2026

yahoo.com

external link

Gain Therapeutics to Participate at ROTH Fifth Annual Healthcare Opportunities Conference

17-09-2026

yahoo.com

external link

Gain Therapeutics Announces Poster Presentation at International Congress of Parkinson’s Disease and Movement Disorders

29-09-2026

yahoo.com

external link

Gain Therapeutics Presents Positive Phase 1b Open-Label Extension Data For Rexaceract Demonstrating Further Evidence of Disease-Modifying Activity Through 12 Months Administration

01-10-2026

yahoo.com

external link

Gain Therapeutics to Attend the 2026 Maxim Growth Summit

08-10-2026

yahoo.com

external link

GAIN THERAPEUTICS INC (GANX:NASDAQ) Sentiment Trend

0 25 50 75 100 2 89 84 82 54 84 85 68 56 86 22-05-2026 27-05-2026 10-06-2026 29-06-2026 16-07-2026 25-08-2026 17-09-2026 29-09-2026 01-10-2026 08-10-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

GAIN THERAPEUTICS INC (GANX:NASDAQ) FAQs

toggle

What is the current price of GAIN THERAPEUTICS INC (GANX:NASDAQ)?

The current price of GAIN THERAPEUTICS INC (GANX:NASDAQ) is $1.15.


toggle

GAIN THERAPEUTICS INC (GANX:NASDAQ) absolute price change since previous trading day?

The absolute price change of GAIN THERAPEUTICS INC (GANX:NASDAQ) since the previous trading day is $-0.11.


toggle

GAIN THERAPEUTICS INC (GANX:NASDAQ) percentage price change since previous trading day?

The percentage price change of GAIN THERAPEUTICS INC (GANX:NASDAQ) since the previous trading day is -8.7302%.


toggle

What is the most recent average sentiment score for GAIN THERAPEUTICS INC (GANX:NASDAQ)?

The most recent average sentiment score for GAIN THERAPEUTICS INC (GANX:NASDAQ) is 69 out of 100.


toggle

What is the most recent average sentiment for GAIN THERAPEUTICS INC (GANX:NASDAQ)?

The most recent sentiment for GAIN THERAPEUTICS INC (GANX:NASDAQ) is .


SEC-8K** Filing Available For GAIN THERAPEUTICS INC (GANX:NASDAQ)

** material developments that could impact a company's financial condition or stock price.

Similar Securities People Also Ask

RAPP (Rapport Therapeutics Inc)
RAPT (Rapt Therapeutics Inc)
CNTX (Context Therapeutics Inc)

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.